Congratulation Roger and Ken!

Discussion in 'Merck' started by Anonymous, Sep 5, 2014 at 3:37 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What and amazing display of competence, focus, and resolve...."Keytruda embodies Merck's unwavering commitment to pursue breakthrough science to help people who are facing the most challenging diseases," CEO Kenneth Frazier said in a statement.
     

  2. Anonymous

    Anonymous Guest

    You are an idiot.
     
  3. Anonymous

    Anonymous Guest

    Are you the same tool that posts crap day after day? We get it....you feel wronged by Merck. Maybe it's because you are just a goof with a negative attitude who wasn't a good rep. Post a picture of yourself....I bet you are not very good to look at also!
     
  4. Anonymous

    Anonymous Guest

    O yes and what does the genius say beyond calling others an idiot.
     
  5. Anonymous

    Anonymous Guest

    agree and congratulations.
     
  6. Anonymous

    Anonymous Guest

    To all of the bitter people who hate working for MRK. Just leave....no need for you to be here.
     
  7. Anonymous

    Anonymous Guest

    You are fools as well as idiots.
     
  8. Anonymous

    Anonymous Guest

    So what did Roger and Ken have anything to do with this approval? Both are mental midgets.
     
  9. Anonymous

    Anonymous Guest

    This drug is projected to have yearly sales ~$150 mil. Woopee.
     
  10. Anonymous

    Anonymous Guest

    Need a drug to cure stupidity.
     
  11. Anonymous

    Anonymous Guest

    This approval was a win for Merck, but Roger and Ken had nothing to do with it.

    Let's not overlook the fact that the pipeline is empty, the products are dropping like flies, the stock is nowhere near where it was even ten years ago and the management is moral void.

    If you own this stock, sell it NOW.
     
  12. Anonymous

    Anonymous Guest

    And you should be the first to take it.
     
  13. Anonymous

    Anonymous Guest

    On Friday morning Jim Cramer said this was good news for Merck regarding the approval however he still has serious concerns about Merck's management.
     
  14. Anonymous

    Anonymous Guest

    Bristol-Myers Squibb filed a lawsuit in US district court seeking unspecified damages from Merck & Co. for allegedly infringing a new immunotherapy patent, Bloomberg reported Friday. According to the litigation, filed in federal court for the District of Delaware, Bristol-Myers Squibb claims "Merck is threatening to exploit that invention" with a later-developed method of treatment, in violation of a patent issued on May 20.
     
  15. Anonymous

    Anonymous Guest

    Hey #12 is that you Ken? Bristol is going to rip you apart in court. Have fun!
     
  16. Anonymous

    Anonymous Guest

    Cramer should be concerned...While Rodger and Ken can pat themselves for the speed with which this breakthrough was approved, the fact of the matter is the know- it- all MRL leadership sat on this compound- which BTW was developed by Organon---- for nearly three years while they build power point slides and committees to review the power point slides. They gutted almost every program, in both Oncology and PC to fund this catch up. Brilliant.
     
  17. Anonymous

    Anonymous Guest

    Pat Roger and Ken on the back all you want for finally getting a drug approved. However, do not count you chickens before they have hatched. Revenues in proportion to the needs of the company is what matters and that success should not be considered a forgone conclusion at this point.
     
  18. Anonymous

    Anonymous Guest

    Did not realize this drug came from The research of Organon. Ken & Rodger should just close the labs and open up a real estate office. Seems to be their new business model.
     
  19. Anonymous

    Anonymous Guest

    The only problem is employees get MRK drugs for free - their biggest customer base wouldn't bring them any revenue.
     
  20. Anonymous

    Anonymous Guest

    Better read the fine print on that one.